These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7652231)

  • 1. [Diagnosis of activated protein C resistance by chronometric test and molecular biology].
    Trossaërt M; Pourkiani N; Conard J; Horellou MH; Delers F; Samama MM
    Rev Med Interne; 1995; 16(6):462-3. PubMed ID: 7652231
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of activated protein C resistance (factor V Leiden).
    Baker R; Thom J; van Bockxmeer F
    Lancet; 1994 Oct; 344(8930):1162. PubMed ID: 7934522
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated protein C resistance in a neonate with venous thrombosis.
    Kodish E; Potter C; Kirschbaum NE; Foster PA
    J Pediatr; 1995 Oct; 127(4):645-8. PubMed ID: 7562293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to activated protein C and factor V Leiden.
    Perry DJ; Pasi KJ
    QJM; 1997 Jun; 90(6):379-85. PubMed ID: 9205675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited thrombophilias.
    Laffan MA; Tuddenham EG
    QJM; 1997 Jun; 90(6):375-8. PubMed ID: 9205674
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activated protein C resistance--an evaluation of current status].
    Hopmeier P
    Wien Klin Wochenschr; 1996; 108(19):599-606. PubMed ID: 9012145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Point mutation G-->A nucleotide 1691 factor V gene as a cause of developing thrombotic complications in a family with plasma resistance to activated protein C].
    Lew Andowski KL; Rozek M; Turowiecka Z; Markiewicz WT; Zawilska K
    Pol Arch Med Wewn; 1996 May; 95(5):464-70. PubMed ID: 8848415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strikes in French public transport and resistance to activated protein C.
    Eschwège V; Robert A
    Lancet; 1996 Jan; 347(8995):206. PubMed ID: 8544587
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired activated protein C-resistance in patients with lupus anticoagulants.
    Ehrenforth S; Radtke KP; Scharrer I
    Thromb Haemost; 1995 Aug; 74(2):797-8. PubMed ID: 8585027
    [No Abstract]   [Full Text] [Related]  

  • 14. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
    Dahlbäck B
    Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance caused by Arg506Gln mutation in factor Va.
    Greengard JS; Sun X; Xu X; Fernandez JA; Griffin JH; Evatt B
    Lancet; 1994 May; 343(8909):1361-2. PubMed ID: 7910348
    [No Abstract]   [Full Text] [Related]  

  • 16. The incidence of activated protein C resistance among patients with deep vein thrombosis and healthy subjects in Osaka.
    Kambayashi J; Fujimura H; Kawasaki T; Sakon M; Monden M; Suehisa E; Amino N
    Thromb Res; 1995 Jul; 79(2):227-9. PubMed ID: 7676410
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial infarction associated with homozygous resistance to activated protein C.
    Holm J; Zöller B; Svensson PJ; Berntorp E; Erhardt L; Dahlbäck B
    Lancet; 1994 Oct; 344(8927):952-3. PubMed ID: 7934361
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C resistance: the commonest hereditary hypercoagulation disorder.
    Schuster KL; Jentschura D
    Br J Surg; 1997 Dec; 84(12):1633-5. PubMed ID: 9448606
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to activated protein C: role in venous and arterial thrombosis.
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Biomed Pharmacother; 1996; 50(6-7):254-60. PubMed ID: 8952864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.